oxymorphone hydrochloride

Generic: oxymorphone hydrochloride

Labeler: xlcare pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxymorphone hydrochloride
Generic Name oxymorphone hydrochloride
Labeler xlcare pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

oxymorphone hydrochloride 5 mg/1

Manufacturer
XLCare Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 72865-130
Product ID 72865-130_4fdf3b7e-f6ff-4d78-a928-c9d47c5bc9d9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210175
DEA Schedule cii
Listing Expiration 2026-12-31
Marketing Start 2020-05-06

Pharmacologic Class

Classes
full opioid agonists [moa] opioid agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72865130
Hyphenated Format 72865-130

Supplemental Identifiers

RxCUI
977939 977942
UPC
0372865131015 0372865130018
UNII
5Y2EI94NBC

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxymorphone hydrochloride (source: ndc)
Generic Name oxymorphone hydrochloride (source: ndc)
Application Number ANDA210175 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (72865-130-01)
source: ndc

Packages (1)

72865-130-01 100 TABLET in 1 BOTTLE (72865-130-01)

Ingredients (1)

oxymorphone hydrochloride (5 mg/1)

Linked Drug Pages (1)

OXYMORPHONE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4fdf3b7e-f6ff-4d78-a928-c9d47c5bc9d9", "openfda": {"upc": ["0372865131015", "0372865130018"], "unii": ["5Y2EI94NBC"], "rxcui": ["977939", "977942"], "spl_set_id": ["1a1d5061-b62a-49fa-a5b2-4970f51416ae"], "manufacturer_name": ["XLCare Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (72865-130-01)", "package_ndc": "72865-130-01", "marketing_start_date": "20200506"}], "brand_name": "OXYMORPHONE HYDROCHLORIDE", "product_id": "72865-130_4fdf3b7e-f6ff-4d78-a928-c9d47c5bc9d9", "dosage_form": "TABLET", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "72865-130", "dea_schedule": "CII", "generic_name": "OXYMORPHONE HYDROCHLORIDE", "labeler_name": "XLCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXYMORPHONE HYDROCHLORIDE", "active_ingredients": [{"name": "OXYMORPHONE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA210175", "marketing_category": "ANDA", "marketing_start_date": "20200506", "listing_expiration_date": "20261231"}